Lv4
468 积分 2021-09-10 加入
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial
1个月前
已完结
Allergy to Alternaria alternata: Comprehensive review from the origin to the therapeutic approach
3个月前
已关闭
Long‐term follow‐up of a randomized, double‐blind, phase III, multi‐centre study to evaluate the safety and efficacy of field‐directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF‐200 ALA versus placebo and the BF‐RhodoLED® lamp
4个月前
已完结
Microneedle technology for allergen immunotherapy via the skin
5个月前
已完结
Bro p 3, an nsLTP1: The first major allergen identified in Broussonetia papyrifera pollen
9个月前
已完结
皖公网安备34019202002308
